Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19807
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Antineoplastic Agents/*therapeutic use,Breast Neoplasms/*drug therapy/pathology/surgery,Chemotherapy, Adjuvant,Disease Progression,Female,Humans,*Neoadjuvant Therapy,Odds Ratio,Randomized Controlled Trials as Topic,Survival Analysis,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19807
ISSN: 1460-2105
Link: http://www.ncbi.nlm.nih.gov/pubmed/15687361
http://jnci.oxfordjournals.org/content/97/3/188.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Mauri-2005-Neoadjuvant versus a.pdf217.07 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons